Concepedia

Dolutegravir-based Prophylaxis

Dolutegravir-Based Prophylaxis is a form of antiretroviral post-exposure prophylaxis that utilizes dolutegravir, an integrase inhibitor, as the cornerstone agent to prevent HIV-1 infection following potential exposure, distinguished by its high genetic barrier to resistance and once-daily dosing regimen.

49

Publications

3.7K

Citations

532

Authors

257

Institutions

Publications per year

2017–2026

44

Parents

Publications

49

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink et al. · The Lancet · 2013 · 546 citations · Full text

, , +12

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Pedro Cahn, Anton Pozniak, Horacio Mingrone et al. · The Lancet · 2013 · 514 citations · Full text

, , +16

Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana

Rebecca Zash, Lewis B. Holmes, Modiegi Diseko et al. · New England Journal of Medicine · 2019 · 394 citations · Full text

, , +17

Major revision version 12.0 of the European <scp>AIDS</scp> Clinical Society guidelines 2023

Juan Ambrosioni, Laura Levi, Jasmini Alagaratnam et al. · HIV Medicine · 2023 · 167 citations · Full text

, , +17

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

Lene Ryom, AG Cotter, Charles Béguelin et al. · HIV Medicine · 2020 · 154 citations · Full text

, , +17

1–5 of 49

Authors

532

  1. GG
    Giovanni Guaraldi

    University of Modena and Reggio Emilia, Italy

    4 publications · 456 citations

    4

    h-index

  2. PC
    Paola Cinque

    Vita-Salute San Raffaele University, Italy

    4 publications · 463 citations

    4

    h-index

  3. CM
    Catia Marzolini

    University Hospital of Basel, Switzerland

    4 publications · 439 citations

    4

    h-index

  4. AW
    Alan Winston

    Imperial College London, United Kingdom

    3 publications · 427 citations

    3

    h-index

  5. PE
    Paul E. Sax

    Brigham and Women's Hospital, United States

    3 publications · 211 citations

    3

    h-index

1–5 of 532

Institutions

257

  1. University of Liverpool

    Liverpool, United Kingdom

    6 h-index

    13 publications

    1.2K citations

  2. Brigham and Women's Hospital

    Boston, United States

    5 h-index

    9 publications

    887 citations

  3. Harvard University

    Cambridge, United States

    5 h-index

    13 publications

    750 citations

  4. University of Cape Town

    Rondebosch, South Africa

    5 h-index

    15 publications

    1K citations

  5. University College London

    London, United Kingdom

    4 h-index

    18 publications

    1.3K citations

  6. Massachusetts General Hospital

    Boston, United States

    4 h-index

    9 publications

    820 citations

  7. University of Modena and Reggio Emilia

    Modena, Italy

    4 h-index

    6 publications

    639 citations

  8. University of Basel

    Basel, Switzerland

    4 h-index

    6 publications

    605 citations

1–8 of 257

Venues

  1. The Lancet HIV

    7 publications · 577 citations

    7

    h-index

  2. AIDS

    4 publications · 120 citations

    4

    h-index

  3. Journal of Antimicrobial Chemotherapy

    JAC · 4 publications · 171 citations

    4

    h-index

  4. International Journal of Antimicrobial Agents

    3 publications · 115 citations

    3

    h-index

  5. The Lancet

    3 publications · 1.1K citations

    3

    h-index

1–5